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LIST OF ABBREVIATIONS 
(ATP)i  intracellular ATP level  
BCECF-AM  2'7'-bis(carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester  
[Ca2+]i  intracellular Ca2+ concentration  
cAMP  cyclic adenosine monophosphate  
AE   anion exchanger (Cl-/HCO3- exchanger) 
CA  carbonic anhydrase 
CaCC  calcium-activated Cl- channel 
CFTR  cystic fibrosis transmembrane conductance regulator Cl- channel 
EIPA   5-(N-Ethyl-N-isopropyl)amiloride 
FURA-2-AM  5-Oxazolecarboxylic acid, 2-(6-(bis(carboxymethyl)amino)-5-(2-(2-
  (bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)-2-  
  benzofuranyl)-5-oxazolecarboxylic acetoxymethyl ester  
DIDS   diisothiocyanostilbene-2,2’-disulfonic acid 
LG  lacrimal gland 
LGDEC lacrimal gland ductal epithelial cells 
NBC   Na+/HCO3- contransporter  
NHE   Na+/H+ exchanger 
PDEC  pancreatic ductal epithelial cells  
pHi   intracellular pH  
pHL   intraluminal pH  
PKA   protein kinase A  
SLC26 solute carrier family 26  
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1. INTRODUCTION 
Vectorial transport of water and electrolytes is a fundamental physiological 
function of epithelial cells which ensures the appropriate volume and electrolyte 
composition of the various fluids. In exocrine glands, fluid and electrolyte secretion is 
carried out by both acinar and ductal cells. The composition of fluid, secreted by these 
cell types varying among glands. Acinar cells mainly secrete isotonic, plasma-like 
fluid which is mostly modified by the ductal cells. The key transporters mediating 
acinar fluid and electrolyte secretion are the Na+/K+/2Cl− cotransporter type 1 
(NKCC1), the Ca2+- activated Cl− channels (CaCC) and the Ca2+-activated K+ 
channels[1–3]. Whereas, ductal fluid and electrolyte secretion are mainly mediated by 
the Na+/HCO3− cotransporter (NBC), the Cl−/HCO3− anion exchanger (AEs), the 
cystic fibrosis transmembrane conductance regulator Cl− channel (CFTR) and the 
CaCC [1,4]. 
 Decrease or damage of ductal fluid secretion can contribute to the 
development of numerous diseases such as pancreatitis, cystic fibrosis (CF) or dry eye 
disease. 
1.1. Basic transport components of epithelial secretion 
 A Danish, Nobel Laureate physiologist, August Krogh concluded from 
his experiments, that metabolic energy was required to maintain the ionic gradients 
between the organism and its external environment. Hans Ussing combined isotopic 
ion fluxes and biophysical approaches to form our basic knowledge of epithelial 
polarity, transport mechanisms, the paracellular pathway, and the origin of epithelial 
“bioelectric” potentials” [5]. Later, Skou and colleagues identified Na+/K+ ATPase as 
an important member in cation transport [6]. This active transport process provides 
the driving force for secondary active transport of various ions and nutrients. These 
principles were applied in the context of active anion secretion, leading to the 
classical cellular model of epithelial secretory functions (Figure 1). Later, researchers 
focused attention on active Cl- secretion and second-messenger pathways. Ussing 
chamber studies on rabbit intestine revealed that cAMP or agents that increase its 
cellular level, stimulated Cl- secretion [7]. Another important pathway for the 
transport of Cl- in epithelial cells is CaCCs activated by intracellular Ca2+ ([Ca2+]i) 
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elevation. These findings have laid the foundation for creating the basic transport 
principles and during the following decades their molecular identities were 
established [1,8].  
Basolateral and apical ion transport mechanisms are essential for cellular 
homeostasis and to maintain apical secretory functions by providing electrochemical 
gradients and by regulating ion transport processes. Although some of the below 
mentioned transporters were not the direct target of the study, it is important to 
describe briefly some of the most important proteins for better understanding of 
epithelial secretory processes. 
1.2. Transporters at the basolateral membrane 
1.2.1. Na+-HCO3- cotransporters  
HCO3--entry across the basolateral membrane is mainly mediated by Na+ 
copuled HCO3- cotransport [9–11]. At least five isoforms of NBC is expressed at the 
basolateral membrane of most epithelia, including pancreatic and salivary gland 
acinar and duct cells [11–13]. However in rabbit LG, if present, NBC activity has 
only marginal role in secretion [14]. NBC is an electrogenic transporter with the 
stoichiometry of 1Na+ : 2HCO3-, although it appears to depend on the cell type in 
which it is expressed [15]. NBC uses the Na+-gradient to mediate basolateral HCO3--
uptake during ductal fluid and HCO3--secretion [4]. 
1.2.2. Na+/K+ -ATPase!
 The basolateral electrogenic Na+/K+-ATPase is essential in establishing the 
electrochemical gradients for secondary active anion secretion. It transports Na+ ions 
out of the cell in exchange for two K+ ions pumped into the cell with the 
stoichiometry of 3:2. Leakage of K+ out of the cell via basolateral (in some cell types 
apical) K+ channels is the primary determinant of membrane voltage [6,16]. In 
epithelia this pump accounts approximately 2/3 of the cells energy expenditure[1].  
1.2.3. Basolateral K+ channels 
Basolateral K+ conductance is essential for K+ recycling. Na+/K+-ATPase 
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activity is the main source of the electrical driving force for anion exit across the 
apical membrane. In response to second-messenger pathways, basolateral K+ channels 
are also activated, to coordinate membrane repolarization with the activation of apical 
Cl- conductance and permit the membrane potentials to repolarize toward the K+ 
equilibrium potential, establishing the electrical driving force for Cl- exit across the 
apical membrane. In many epithelia, the basolateral K+ conductance is composed of at 
least two K+ channel types like the cAMP/PKA activated KCNQ1 and the Ca2+-
activated channel KCNN4 [17–19].  
1.2.4. Na+/H+ exchangers 
The Na+/H+-exchanger (NHE) family has five members located in the plasma 
membrane (NHE1-5) [12,13]. In glandular duct epithelia NHE1 is localized at the 
basolateral membrane and is essential for cytoplasmic pH homeostasis of the cells 
[14,20–22]. NKCC1 and NHE1 are the main sources of the basolateral Na+-uptake 
which is essential for the Na+/K+-ATPase activity in secretory epithelia and it also can 
provide a minor portion of basolateral HCO3- uptake during secretion [4,23–26].  
1.2.5. Basolateral NKCC1 
NKCC1 mediates the basolateral Cl- uptake in most epithelial cells. The driving 
force for Cl- uptake and accumulation is supplied by the chemical gradient of Na+ 
established by NKCC1 and NHE1 which process is electrically neutral. Ultimately 
NKCC1 determines the overall rate of Cl- secretion. The activation of NKCC1 
generally follows the activation of CFTR and K+ channels resulting in Cl- and K+ exit 
and decrease in the cell volume. NKCC1 activity is the main source of the basolateral 
Cl--uptake which is secreted across the luminal membrane to drive fluid secretion in 
secretory glands [17,27,28]. 
1.2.6. Basolateral anion exchangers 
Na+-coupled Cl- entry at the basolateral membrane is not the only possible 
source of intracellular Cl-. Fluid secretion showed to be insensitive to the NKCC1 
inhibitors but was sensitive to inhibitors of carbonic anhydrase (CA), NHEs and AEs 
in salivary glands and other epithelia. This component of secretion was assigned to 
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the parallel operation of basolateral AEs- and NHEs [28,29]. The contribution of AEs 
in basolateral Cl- uptake has been suggested in various epithelia [30,31]. 
1.3. Transporters at the apical membrane 
1.3.1. Apical CFTR  
CFTR is one of the members of the ATP-binding cassette (ABC) proteins. 
Members of this transporter family are composed of two membrane-spanning 
domains (MSD1 and 2) and two nucleotide-binding domains (NBD1 and 2) [1,32]. 
CFTR contains a central regulatory (R) region which contains nine consensus 
sequences for phosphorylation by protein kinase A (PKA) and several additional sites 
of phosphorylation by other kinases (e.g., AMPK, PKC). CFTR has another PKA 
phosphorylation site in the regulatory insertion of NBD1. As discussed below, CFTR 
is the predominant pathway for secretion in response to agonists that act via 
cAMP/PKA-dependent phosphorylation, although it is not the only pathway for apical 
Cl- exit. In addition, CFTR exhibits a significant conductance to HCO3-, which 
highlights its importance in pancreatic HCO3- secretion [4]. 
1.3.2. Calcium-activated chloride channels 
CaCC is a major pathway for the transport of Cl- in most cell types, but it was 
first characterized in secretory epithelium. CaCC is activated by rapid [Ca2+]i increase 
and also by membrane depolarization. CaCC is the main apical Cl- pathway during 
muscarinic stimulation of LGs [33,34]. Later, this pathway has been identified in 
other epithelial cells, where a wide range of Ca2+-mobilizing agonists, like 
charbamylcholine, stimulate it [1,35]. We have still limited information about the 
CaCC protein. The most promising candidate to mediate CaCC is TMEM16A 
[36,37]. 
1.3.3. Luminal anion exchangers 
HCO3- secreting epithelial cells, such as PDECs express electrogenic AEs on the 
luminal membrane. AEs allow the cells to transport HCO3- across the apical 
membrane and to establish the high intraluminal HCO3- concentration during 
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stimulation [4,38]. CFTR mutations, associated with exocrine pancreatic 
insufficiency, also establish a major deficiency in the apical CFTR-dependent Cl-/ 
HCO3- exchange activity [39]. Recent studies in the field revealed the “puzzling” role 
of CFTR in HCO3- secretion (Figure 1A). The luminal Cl- concentration ([Cl-]L) is 
high in the proximal pancreatic duct, therefore CFTR functions as a Cl- channel, 
providing Cl- for the Cl-/HCO3- exchange through the SLC26A6 and A3. In the distal 
pancreatic ducts, where the [Cl-]L and intracellular Cl- concentration ([Cl-]i) is low, 
HCO3- secretion through CFTR can play an important role [35,40]. 
1.4. Epithelial secretion in exocrine glands 
Fluid and electrolyte secretion is a vital function of all epithelia and is required for 
the survival of the tissue however the secretory processes widely differ among organs. 
Aberrant fluid and anion secretion is associated with various epithelial diseases, such 
as CF, pancreatitis, Sjögren’s syndrome and other epithelial inflammatory and 
autoimmune diseases [1,4].  
1.4.1. Lacrimal gland  
 Preocular tear film is an essential protector of the ocular surface. Tear is 
produced predominantly in the exocrine tubuloacinar LGs. Appropriate amount of 
balanced electrolyte, protein and mucin composition of fluid secreted by the LG is 
fundamental for maintaining preocular tear film integrity. Such as other exocrine 
tubuloacinar glands, LG is composed mainly of three types of cells: acinar, ductal and 
myoepithelial cells [20,41]. Acinar cell functions are widely studied, resulting in 
broad spectrum of information, however much less is known about the possible 
secretory function of duct cells [42–44]. It has been proposed that primary acinar fluid 
is modified by ductal secretory processes: an elevated K+ and Cl- content of the final 
product evolves during passage of fluid through the ductal tree [2,42]. Although acini 
are the determining structures of tear production, the secretory role of ducts beside 
their piping function was also suspected for a long while. Modifications of K+ and Cl- 
content of primary acinar fluid by ductal secretory processes were also proposed 
earlier. However, the role of LG ductal epithelium on fluid, electrolyte and protein 
secretion is not well understood.  
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The first experimental model for the investigation of lacrimal duct function 
was adapted and applied by our group. Using short-term cultured duct segments 
allowed studying the role and regulation of various ion transporters in the lacrimal 
duct. These results showed the functional presence of a Na+ dependent proton efflux 
mechanism (NHE) and a Cl- dependent HCO3- efflux mechanism (AE) using pH-
sensitive fluorescent dye in LG ductal cells [14]. Ca2+ and cAMP signaling pathways 
in activation of epithelial fluid and electrolyte secretion are well studied in different 
gland types such as pancreas and salivary gland, however we are lacking of 
information about LG secretory functions. Based on findings from our laboratory and 
gene expression studies a scematic figure of lacrimal gland ductal secretion was 
designed (Figure 1B) [14,45–48].  
Dry eye disease is one of the most frequently diagnosed ocular surface pathology. 
Presently substitution of tear fluid with arteficial tear drops is the main, mostly 
insufficient, intervention to manage dry eye without treating the underlying 
pathologic alterations since the causative factors of the disease is mostly unknown 
[49–51]. Our knowledge about LG function is far from complete and therefore the 
more detailed understanding of the physiology and pathophysiology of the lacrimal 
gland is essential.  
1.4.2. Pancreas 
Besides its endocrine function pancreas has an important exocrine function 
participating in digestion. There are two major cell types in the exocrine pancreas, the 
acinar and ductal cells. Both cell types play role in the secretion and the release of the 
pancreatic juice. Acinar cells secrete pancreatic juice rich in NaCl and digestive 
enzymes which travels through the pancreatic ductal system into the duodenum. 
Ductal cells secrete a HCO3- rich fluid and modify the electrolyte composition of the 
juice by the secretory and absorptive processes. Pancreatic duct HCO3- secretion can 
be divided to basolateral accumulation of the HCO3- ions and the secretion into the 
duct lumen across the apical membrane. HCO3- accumulation is mainly carried out by 
the NBC, whereas a minority of HCO3- forms by the conversion of CO2 to HCO3- 
[4,10]. PDEC express on the luminal membrane electrogenic AEs (SLC26A6 and 
possibly SLC26A3) and the CFTR Cl- channel [52,53]. These transporters are 
essential for pancreatic ductal HCO3-  secretion to generate the 140mM intraluminal 
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HCO3- concentration [4,38]. Recent evidences suggest that pancreatic HCO3- 
secretion is playing a crucial role in the pathophysiology of the pancreas. Impaired 
ductal electrolyte and fluid secretion leads to acinar cell damage and to primary defect 
in membrane trafficking at the apical plasma membrane of acinar cells [54]. 
Intraluminal pH is also play a central role in normal pancreatic functions, since 
luminal acidosis may elevate the risk of AP [55,56]. Different etiological factors also 
can contribute to the development of AP such as excessive ethanol consumption, 
smoking, viral infections and also gallstones [57–61]. The obstruction of the common 
biliopancreatic duct by a gallstone is a frequent cause of AP. Although, the exact 
mechanism is not completely understood [60,62,63]. One of the most accepted 
theories is that bile reflux into the pancreatic ductal system leads to AP. We know 
from animal studies, that retrograde infusion of bile acids into the pancreatic duct 
triggers pancreatitis [3,64,65]. Therefore the cytotoxic effects of bile acids have been 
widely investigated in the pancreas [66–69]. Initial studies, in which the main 
pancreatic duct was perfused with various bile acids, demonstrated that in the mM 
range hydrophobic bile acids cause mucosal damage and increase the permeability of 
the pancreatic ducts to different ions [70,71]. Bile acids also induced Ca2+ release 
from the intracellular Ca2+ stores [66]. Moreover, Voronina et al. showed that 
taurolithocholicacid 3-sulfate (TLC-S) decreased  intracellular ATP ((ATP)i) in 
pancreatic acinar cells and caused the loss of mitochondrial membrane potential 
((ΔΨ)m) [72,73]. Studies from our workgroup demonstrated that the nonconjugated 
bile acid chenodeoxycholic acid (CDCA) has dose-dependent dual effects on 
pancreatic HCO3- secretion, which might be explained by the intracellular Ca2+ 
signals, decrease in the ATPi, mitochondrial damage and the inhibition of acid/base 
transporter activity caused by CDCA [68,74]. The cytotoxic effect of CDCA is 
basically attributed to its detergent characteristic, which is responsible for the 
disruption of the membrane integrity and consequently the release of intracellular 
constituents. However, several studies suggest that non-detergent effects of bile acids 
are also involved in the bile-induced cellular injury [66,69,73]. It has been recently 
demonstrated that CDCA induces ATP release from both ductal and acinar cells, 
which probably play a role in the CDCA-induced [Ca2+]i elevation [75]. In the 
absence of ATPi, the acid/base transporters fail to function properly, which finally 
causes decreased fluid and HCO3- secretion [74]. Impaired fluid secretion can lead to 
pancreatic injury and likely contributes to the development of pancreatitis [3,76]. 
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Nevertheless not every bile acid has cell damaging effect. Ursodeoxycholic 
acid (UDCA) is a secondary, hydrophilic bile acid, which is currently used for 
gallstone dissolution and considered as first-choice therapy in cholestatic diseases[77–
80]. The mechanism by which UDCA increases liver function is not completely 
understood. Basically, there are three concepts for the action of UDCA: (i) 
stimulation of hepatobiliary secretion (ii) displacement of the hydrophobic, toxic bile 
acids from the liver and (iii) direct cytoprotection against toxic bile acids. The 
cytoprotective effects of UDCA or its taurin-conjugated form, tauroursodeoxycholic 
acid (TUDCA) have been widely investigated in the liver. Studies on hepatocytes 
have shown that UDCA pretreatment significantly reduces bile acid-induced opening 
of the mitochondrial permeability transition pore (mPTP) and consequently apoptosis, 
indicating that stabilization of the mitochondrial membrane, at least in part, plays an 
important role in the cytoprotective action of UDCA [81–85].  
This remarcable effect of UDCA on bile acid-induced hepatocellular injury 
raises up the question, whether UDCA has a similar effect on the pathophysiology of 
other bile acid-related diseases. 
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Figure 1. Schematic figure of pancreatic and lacrimal duct secretory processes: In 
the pancreatic duct the entry of anions across the basolateral membrane is mainly driven 
by NKCC1, NBC and AEs. Apical Cl- and HCO3- efflux is mediated by cAMP- (CFTR) 
and Ca2+-activated (CaCC) anion conductances and AEs (SLC26A6 and SLC26A3). In 
the proximal ducts, where the [Cl-]L is high, HCO3- is secreted via the electrogenic AEs, 
driven by the high [Cl-]L. Under these conditions CFTR functions as a Cl- channel. In the 
distal ducts, where the [Cl-]L is low, the low intracellular Cl- concentration ([Cl-]i) 
induces the phosphorylation of CFTR, switching its ion selectivity to HCO3-. Apical 
HCO3- transport is inhibited under these conditions (A). In the LG basolateral Cl- uptake 
is mainly mediated by NKCC1 and AEs. The luminal secretory processes are 
supposedly mediated by CFTR and CaCC. There is no evidence of functionally active 
AE on the apical membrane of lacrimal gland ductal epithelial cells (B). Transport of 
fluid is mediated by transcellular and also paracellular pathways in both cell types. 
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2. AIMS OF THE STUDY 
2.1. Investigation of lacrimal gland ductal secretion 
 Our understanding of lacrimal gland function is far from complete and below 
that can be experienced in other areas of exocrine glands. This is especially true for 
the LG duct structures and is in striking contrast with the significant amount of 
information available in case of pancreatic or salivary gland ducts. Until recently 
there was no experimental method available for the investigation of LG duct function. 
In the past few years laser capture microdissection technique was introduced for the 
investigation of gene expression profile, and the first experimental method suitable to 
study LG duct function was described by our laboratory [14,45]. Thanks to these new 
methods there are continuously gathering experimental results supporting the notion 
that LG duct structure may play an important role in lacrimal function. In contrast 
there are no data supported by experimental results regarding the contribution of 
ductal cells in fluid secretion of the LG.  
Our specific aims were:  
! To determine the osmotic water permeability of ductal epithelium by 
means of calculation of filtration permeability (Pf),  
! To investigate lacrimal gland ductal fluid secretion by means of 
measurement of  fluid secretion evoked by potential agonists (forskolin 
and carbachol) seeking for evidence of secretory function of lacrimal 
ductal system.  
2.2. The effect of bile acids on pancreatic ductal cells 
 Previous studies shown that bile acids such as CDCA strongly inhibits ion 
transporters through the destruction of mitochondrial function, resulting in impaired 
pancreatic ductal fluid and HCO3- secretion [68,74]. This effect of bile acids may 
have significance in the pathomechanism of AP. UDCA is known to protect the 
mitochondria against hydrophobic bile acids and has ameliorating effect on cell death 
[81,84]. Since the CDCA-induced failure in pancreatic ductal function is also strongly 
associated with mitochondrial damage, we aimed to investigate, using in vitro and in 
vivo approaches, if UDCA pretreatment is able to prevent the CDCA-induced ductal 
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injury.  
Our specific aims were:  
! To investigate the effect of UDCA pretreatment on CDCA-induced 
pancreatic ductal injury on isolated in vitro 
! To study the effect of UDCA pretreatment in CDCA-induced AP in vivo. 
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3. MATERIALS AND METHODS 
3.1. Animals 
Rabbits 
Adult male New Zealand white rabbits weighing 2-2.5 kg were used (Devai 
Farm Kondoros Hungary). The animals were narcotised with a mixture of ketamine 
(40 mg/ml) and xylazine (10 mg/ml) and were euthanized with pentobarbital overdose 
(80 mg/kg). LGs were carefully dissected as described earlier [14].  
Guinea pigs 
 Guinea pigs weighing 150-250 g were used in order to examine the effect of 
bile acids on pancreatic ductal HCO3- secretion. Animals were killed humanly by 
cervical dislocation, and then the pancreas was removed. 
Rats 
Male SPRD rats were used for experiments as described below in the section 
of the „Induction of pancreatitis”. 
 
All animals were kept at a constant room temperature of 22±2 oC, under 12-h 
light and dark cycles, and were allowed free access to water and standard laboratory 
chow (Biofarm, Zagyvaszántó, Hungary). 
3.2. Ethics 
 All animal experiments were conducted in compliance with the Guide for the 
Care and Use of Laboratory Animals (National Academies Press, Eight Edition, 
2011), with the 2010/63/EU guideline and the Hungarian 40/2013 (II.14.) government 
decree and were approved by the Institutional Animal Care and Use Committee of the 
University of Szeged (I-74-3/2012 MÁB) and also by an independent committee 
assembled by national authorities (XII./3773/2012.). LG experiments were also 
conducted in compliance with the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research.  
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3.3. Solutions and chemicals  
Chromatographically pure collagenase was obtained from Worthington 
(Lakewood, NJ, USA), Isolation solution contained DMEM (Dulbecco modified 
Eagle medium) supplemented with 100 U/ml collagenase and 1 mg/ml bovine serum 
albumin. Storage solution contained DMEM and 3% (wt/vol) bovine serum albumin. 
Culture solution contained McCoy 5A tissue culture medium, 10% (vol/vol) fetal calf 
serum, and 2 mmol/l glutamine. Ingredients of media (DMEM, McCoy, fetal calf 
serum, glutamine and bovine serum albumin) were purchased from Sigma-Aldrich 
(Budapest, Hungary).   
Standard HEPES-buffered solution contained (mmol/l): 140 NaCl (67.5 NaCl 
in case of hypotonic solution: 145 mosM), 5 KCl, 2 CaCl2, 1 MgCl2, 10 D-glucose 
and 10 Na-HEPES and pH was set to 7.4 with HCl at 37 oC (290 mosM).  
The standard HCO3-/CO2-buffered solution contained (mmol/l): 115 NaCl, 25 
NaHCO3, 5 KCl, 1 CaCl2, 1 MgCl2, 10 D-glucose and was gassed with 95% O2/5% 
CO2 at 37 ℃. 
CellTak was obtained from Becton Dickinson Labware (Bedford, MA, USA). 
Carbachol (carbamoylcholine chloride), forskolin, bumetanide, dihydro-4,4’-
diisothyocyanato-stilbene-2,2’-disulphonic acid (H2DIDS), 5-(N-ethyl-N-
isopropyl)amiloride (EIPA) and soybean trypsin inhibitor were obtained from Sigma-
Aldrich (Budapest, Hungary).  
3.4. Isolation and culture of lacrimal and pancreatic duct segments 
Rabbit LG interlobular ducts were isolated as previolusly described by our 
laboratory based on pancreatic duct isolation methods [14]. Briefly, LGs were 
dissected and transferred to a sterilized small flat-bottom glass flask containing a cold 
(+4oC) storage solution. Isolation solution was injected into the interstitium of the 
glands and the tissue pieces were transferred to a glass flask containing 2 ml of 
isolation solution for incubation in shaking water bath at 37 oC for 25 minutes. 
Isolation solution was removed after incubation and 5 ml of fresh cold storage (+4oC) 
solution was added to the flask. Tissue samples were transferred to a glass microscope 
slide and viewed under stereo microscope. Interlobular ducts were micro-dissected 
and after microdissection, intact LG ducts were transferred to the culture solution in a 
 18 
Petri dish. Ducts were cultured overnight in a 37oC incubator gassed with 5 % 
CO2/95 % O2. 
 Guinea pig pancreatic intra/interlobular ducts were isolated and then cultured 
as described above except that, all used mediums were supplemented with 0.01% 
trypsin inhibitor [86]. 
3.5. Measurement of osmotic water permeability and ductal fluid secretion of 
lacrimal gland interlobular duct epithelium  
Ends of LG ducts sealed during overnight incubation forming a closed luminal 
space. Fluid secretion (or osmotically determined fluid movement) into the closed 
intraluminal space of the ducts resulted in ductal swelling which could be analyzed 
using the videomicroscopic method [87,88]. Cultured LG duct segments were 
carefully transferred to a coverslip pretreated with Cell-Tak. The coverslip formed the 
base of a perfusion chamber mounted on an inverted microscope (Nikon Diaphot 
Inverted Tissue Culture Microscope). The chamber was perfused with solutions via an 
infusion pump at approximately 2.5 ml/min at 37 °C. Ducts were visualized at high 
magnification (40 x objective). Bright-field images were acquired at set time intervals 
(5 seconds in case of osmotic permeability measurements and 1 minute in case of 
ductal fluid secretion experiments) using a charge-coupled device camera coupled to a 
PC. Both the duration of experiments and the time intervals between images were 
defined in Image J software. An image series in TIFF-format were generated 
containing all of the images collected from the same experiment. Scion Image (Scion 
Corporation, Frederick, MD, USA) software was used to analyze changes to obtain 
values from the area corresponding to the luminal space in each image. 
The initial lumen length (L0) and the lumen area (A0) were measured directly 
from the pixel intensities on the first image. The lumen diameter was calculated 
assuming cylindrical setup of the duct, from the formula 2R=A0/l0. The luminal 
surface area was calculated as 2πR0L0, also assuming cylindrical geometry. 
Measurements from subsequent individual images were normalized to the first lumen 
area in the series (A0) thus giving values for the relative area (AR=A/A0). Relative 
luminal volume (VR=V/V0) of the ducts was then calculated from the relative image 
area. These calculations were done using Scion Image and Microsoft Excel software. 
Luminal volume change after exposure to hypotonic solution was measured for the 
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calculation of osmotic permeability as follows: ducts were perfused with isotonic 
HEPES-buffered solution (290 mosM) for 5 minutes after equilibration, than the 
perfusate was changed to hypotonic HEPES-buffered solution (145 mosM) [89]. The 
osmotic water permeability constant ([Pf]=µm/s) was calculated using the initial 
volume (V0=πR02l0), the initial slope of the relative volume increase (d(V/V0)/dt), the 
initial luminal surface area (2πR0l0), and the molar volume of water (Vw=18x1012 
µm/mol) as follows [90]:  
Pf=[V0d(V/V0)/dt]/[S0Vw(osmin-osmout)] 
where osmin -osmout is the difference between inner and outer mediums osmolarity. In 
this case osmin=290 mOsm and osmout=145mOsm. 
In the case of fluid secretion measurement, carbachol or forskolin were added to the 
perfusate after 10 minutes superfusion with HEPES-buffered or HCO3-/CO2-buffered 
solution. At the end of each experiment, perfusion was changed to hypotonic solution 
for 5 minutes in order to confirm epithelial integrity. Complete sealing was proved by 
rapid swelling as a response to hypotonic challenge. Data obtained from ducts not 
showing swelling response were discarded. 
3.6. Bile acid treatments 
 Pancreatic ducts were treated with bile acids as follows: no treatment (control 
group), 5 minutes CDCA (1 mM) treatment (CDCA group), 24 h UDCA (0.5 mM) 
treatment (UDCA group) and 24 h preincubation with 0.5 mM UDCA and then 
parallel incubation for further 5 minutes with 1 mM CDCA (UDCA+CDCA group). 
3.7. Measurement of intracellular Ca2+ concentration, pH and ATP level  
 [Ca2+]i, pHi and ATPi were measured by loading the pancreatic ducts with the 
Ca2+- sensitive fluorescent dye, FURA 2-AM (5 µM, 60 min, in the presence of 
0.05% pluronic F-127), the pH-sensitive fluorescent dye, BCECF-AM (2 µM, 30 min) 
and the Mg2+-sensitive fluorescent dye, MgGreen-AM (5 µM, 60 min, in the presence 
of 0.05% pluronic F-127), respectively. Ducts were attached to a poly-l-lysine-coated 
cover slip (24 mm) forming the base of a perfusion chamber and were mounted on the 
stage of an inverted fluorescence microscope linked to an Xcellence imaging system 
(Olympus, Budapest, Hungary). Ducts were then bathed with different solutions at 
 20 
37oC at the perfusion rate of 5-6 ml/min. 6-7 region of interests (ROIs) were 
examined in each experiments and one measurement per second was obtained.  
 To determine the changes of [Ca2+]i, cells were excited with 340 and 380 nm 
wavelength and the changes in [Ca2+]i were calculated from the 340/380 fluorescence 
ratio measured at 510 nm. In order to estimate pHi, cells were excited with 490 and 
440 nm wavelength, and the 490/440 fluorescence emission ratio was measured at 
535 nm. The calibration of the fluorescent emission ratio to pHi was performed with 
the high-K+-nigericin technique, as previously described [91,92]. Changes in [ATP]i 
was determined by exciting the cells at a wavelength of 490 nm, with emitted light 
monitored at 535 nm. Fluorescence signals were normalised to initial fluorescence 
intensity (F/F0) and expressed as relative fluorescence. 
3.8. Measurement of the activity of acid/base transporters 
In order to estimate the activity of the NHE, the NBC and the AEs the NH4Cl 
prepulse technique was used. Briefly, exposure of PDECs to 20 mM NH4Cl for 3 
minutes induced an immediate rise in pHi due to the rapid entry of lipophilic, basic 
NH3 into the cells. After the removal of NH4Cl, pHi rapidly decreased. This 
acidification is caused by the dissociation of intracellular NH4+ to H+ and NH3, 
followed by the diffusion of NH3 out of the cell. In standard Hepes-buffered solution 
the initial rate of pHi (ΔpH/Δt) recovery from the acid load (over the first 60 sec) 
reflects the activities of NHEs, whereas in HCO3-/CO2-buffered solutions represents 
the activities of both NHEs and NBC [93,94]. In order to estimate CBE activity the 
initial rate of pHi recovery from alkalosis in HCO3-/CO2-buffered solutions was 
analyzed. Previous data have indicated that under these conditions the recovery over 
the first 30 seconds reflects the activity of CBE [93,94].  
In order to evaluate transmembrane base flux (J(B-)) the following equation 
was used: J(B-)= ΔpH/Δt X βtotal, where ΔpH/Δt was calculated by linear regression 
analysis, whereas the total buffering capacity (βtotal) was estimated by the Henderson–
Hasselbach equation using the following formula: βtotal = βi + βHCO3- = βi + 
2.3x[HCO3-]i. We denote base influx as J(B) and base efflux (secretion) as -J(B-). 
 21 
3.9. Measurement of mitochondrial membrane potential 
 Mitochondrial membrane potential (ΔΨm) was measured using the lipophilic, 
mitochondria-selective fluorescence dye, TMRM. Accumulation of TMRM in the 
mitochondria is depend on the ΔΨm. Pancreatic ducts were preincubated with TMRM 
(1 µM) for 30 min at 37oC and transferred to a poly-l-lysine-coated cover slip (24 
mm) forming the base of a perfusion chamber. Ducts were than perfused continuously 
with solutions at 37oC at a rate of 2-2.5ml/min. The perfusion solutions were 
complemented with 100 nM TMRM to avoid dye leakage. Changes in ΔΨm were 
monitored using a Fluoview 10i-W confocal microscope (Olympus, Budapest, 
Hungary). 5-10 ROIs (mitochondria) of 5-10 cells were excited with light at 543 nm 
and the emitted light was captured between 560–650 nm. We have employed the 
dequench method for the estimation of ΔΨm. At the applied concentration of TMRM, 
depolarisation of the mitochondria causes release of the dye and it’s dequenching in 
the cytosol. Thus increase in fluorescence intensity reflects a decrease in ΔΨm. 
Fluorescence signals were normalised to initial fluorescence intensity (F/F0) and 
expressed as relative fluorescence. 
3.10. Measurement of mitochondrial permeability transition pore 
opening 
 To measure mitochondrial inner membrane permeabilization and/or the 
opening of the mitochondrial permeability transition pore (mPTP), we used the 
calcein-cobalt dequenching technique. Calcein-AM is a lipid-soluble fluorescent dye 
which diffuses into all subcellular components including mitochondria. Co2+ is a 
quencher of calcein which can enter to the cytoplasm but cannot pass through the 
mitochondrial membrane. Upon transient opening of mPTP, Co2+ diffuses into the 
mitochondria and quenches the mitochondrial calcein fluorescence which results in a 
decrease of fluorescence intensity. Pancreatic ducts were loaded with calcein-AM (1 
µM) for 30 min then with CoCl2 (1 mM) for further 10 min. Ducts were then washed 
at 37oC at the perfusion rate of 5-6 ml/min and imaged using an Olympus IX71 
fluorescence microscope (Olympus, Budapest, Hungary). 5-6 ROIs were excited with 
light at 495 nm and the emitted light was captured at 515 nm. Fluorescence signals 
were normalised to initial fluorescence intensity (F/F0) and expressed as relative 
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fluorescence. 
3.11. TUNEL cell death assay 
 For detection of cell death we used the terminal deoxyribonucleotidyl 
transferase (TDT)-mediated dUTP-digoxigenin nick end labelling (TUNEL) assay 
(Roche Diagnostics, Mannheim, Germany). Intra-interlobular pancreatic ducts were 
treated with bile acids as previously described. Control and bile acid-treated isolated 
duct segments were fixed with 4% paraformaldehyde overnight and then cryosection 
and staining of the samples were performed according to the manufacturer’s protocol. 
The CDCA-treated groups were incubated for 3 h in culture media before fixation. To 
normalize TUNEL reaction we used tonsil samples. Pictures were taken with the use 
of a Zeiss AxioImager fluorescent light microscope (Carl Zeiss MicroImaging, 
Thornwood, NY, USA) fitted with a PixeLINK CCD camera (PixeLINK, Ottawa, 
ON, Canada) 
3.12. Transmission electron microscopy 
 For electron microscopic studies, ducts were fixed in 2.5% glutaraldehyde 
immediately after isolation(“Keratoconjunctivitis Sicca and Corneal Ulcers.,” n.d.). 
Samples were then postfixed in 1% osmium tetroxide, dehydrated in a series of 
graded ethanols, and subsequently embedded in epoxy resin. Ultrathin sections were 
contrasted with uranyl acetate and lead citrate. Tissue sections were analyzed under a 
transmission electron microscope (CM10; Philips, Eindhoven, The Netherlands). 
3.13. Induction of acute pancreatitis 
Male SPRD rats weighing 200-250 g were used for AP experiments. Animals 
were fasted 12 h before the surgical procedure. Ursodeoxycholic acid (Ursofalk) was 
purchased from Dr Falk Pharma Ltd. UDCA was dissolved in 2 mL of tap water and 
250 mg/kg of body weight was administered orally (gavage) for two weeks. Control 
animal were only treated with same amount of tap water. Last UDCA treatment was 
performed one day before the pancreatitis induction. Rats were anesthetized with 
intraperitoneal injection of a cocktail, containing of 50 mg/kg Ketamine and 10 mg/kg 
Xylazine. After the anesthesia rats were shaven and the abdominal cavity was opened 
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with median laparotomy. The common bile duct was temporary occluded with a 
vessel clip. Duodenum was punctured with a 0.4-mm diameter needle connected to 
polyethylene tubing. The polyethylene tube was placed into the major pancreatic duct 
and 1 ml/kg 1 % sodium-CDCA (dissolved in physiologic saline) was administered 
via retrograde ductal infusion with 1 ml/min speed with an infusion pump (TSE 
System GmbH, Bad Homburg, Germany). Control animals received intraductal 
physiological saline instead of bile acid. After bile acid or physiological saline 
infusion, vessel clip and the polyethylene tube were removed and the abdominal wall 
and skin were closed.  Rats were sacrificed 24 h later of the surgical procedure.  
3.14. Histologic examination and laboratory parameter measurements 
Terminal anesthesia was performed with 50 mg/kg sodium pentobarbitale. 
Abdominal and thoracic cavity was opened with a median laparotomy and 
thoracotomy and blood was collected with cardiac puncture. Pancreas was removed 
immediately after the blood collection and it was trimmed from fat and lymphatic 
tissues on ice. Pancreata were dissected and only the part of head and body were used 
for histological analysis and for laboratorial measurements. The pancreatic tail didn’t 
show any necrosis or signs of inflammation therefore it was not used later. The 
pancreatic head and body were longitudinally dissected and one part of pancreas was 
put into 6 % neutral formaldehyde solution, however other part was immediately 
frozen in liquid nitrogen. These parts of pancreata were stored at -80 °C until for use. 
The collected blood was centrifuged at 4 °C with 2500 RCF for 15 min. Sera were 
collected and it was stored at -20 °C until for use. Serum amylase activity was 
measured with a commercial colorimetric kit (Diagnostikum) with a FLUOstar 
OPTIMA (BMG Labtech) microplate reader at 405 nm. Wet pancreatic tissues were 
measured and they were dried for 24 h at 100 °C. The dry weight-wet weight ratio 
was calculated. Pancreatic samples were prepared for hematoxylin and eosin staining. 
Pancreatic histological samples were scanned.  Necrotic areas were detected and 
analyzed with Image J (National Institutes of Health, Bethesda, MD, USA) software. 
Necrotic areas were compared to the total analyzed pancreatic area. 
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3.15. Statistical Analysis 
 Data are expressed as means±SEM. Significant difference between groups 
was determined by analysis of variance (ANOVA). Statistical analysis of the in vitro 
data was performed using the Mann–Whitney U test. In vivo experiments were 
evaluated by using ANOVA followed by Bonferroni or Dunnett’s multiple 
comparison post hoc test. Probability values of p<0.05 were accepted as being 
significant in every cases. 
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4. RESULTS 
4.1. Investigation of lacrimal gland ductal secretion 
4.1.1. Osmotic water permeability of lacrimal gland interlobular duct 
epithelium 
 The perfusion of the ducts with hypotonic solution the luminal area resulted in 
rapid increase in the luminal area, indicating that the NaCl gradient caused rapid 
water flux into the closed luminal space. Pf proved to be 60.53 µm/s (± 19,76).  Figure 
2. shows the changes in the relative luminal volume (Vr) after the change in bath 
osmolarity. Data were obtained from nine ducts (n=9) originated from three different 
animals.  
 
Figure 2. Osmotic permeability of rabbit interlobular duct epithelium. LG ducts 
were isolated from the LG of rabbits. Changes in the relative luminal volume (Vr) 
induced by a 50% reduction in the osmolarity of the perfusate are shown. 
Measurements were performed by video microscopy. Bright field images were 
captured at 5-second intervals. Data was obtained from nine ducts isolated from three 
different animals and is presented as the mean ± SEM. 
4.1.2. Forskolin-stimulated fluid secretion of lacrimal gland interlobular 
ducts in the presence and in the absence of HCO3- 
LG duct secretion to forskolin stimulation were investigated both in HCO3- 
free (HEPES-buffered) and in HCO3-/CO2-buffered solutions. At first step ducts were 
superfused with HEPES-buffered solution for 10 minutes, and then 10 µmol/l 
forskolin was added to the bath. Ducts remained unchanged in HEPES-buffered 
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solution, but during forskolin stimulation, rapid, sustained luminal volume increase 
was observed which remained relatively unchanged over a 30-minutes period (Figure 
3A). To evaluate the possible role of HCO3- in forskolin-evoked fluid secretion, ducts 
were superfused with HCO3-/CO2-buffered solutions for 10 minutes, and then 
forskolin was added to the bath. There was no detectable secretion in HCO3-/CO2-
buffered solution, while rapid secretion could be observed as an effect of forskolin 
stimulation without decline in the swelling response over a 30 minutes period (Figure 
3B). The secretory effect of forskolin did not differ in HEPES-buffered and in HCO3-
/CO2-buffered solution.  
 
Figure 3. Effect of forskolin on ductal fluid secretion in rabbit LG interlobular 
ducts in the presence or in the absence of HCO3-. (A) Ducts were superfused with 
HEPES-buffered solution throughout the experiments. From 10 minutes, ducts were 
exposed either to 10 lM forskolin (filled square) or to no agonist (empty circle). (B) 
Ducts were superfused with HEPES-buffered solution for 10 minutes (data not 
shown) and then the perfusate was switched to HCO3-/CO2 buffered solution. After 10 
minutes of superfusion with HCO3-/CO2 buffered solution, ducts were exposed either 
to 10 lM forskolin (filled square) or to no agonist (empty circle). Changes in relative 
luminal volume (Vr) are shown. Data was obtained from five ducts isolated from at 
least three different animals in each series and is presented as the mean ± SEM. 
4.1.3. Effects of different inhibitors on fluid secretion 
 The above described results indicate that LG interlobular ducts are able to 
secrete fluid in response to forskolin stimulation in HEPES-buffered solution in the 
absence of extracellular HCO3-, another anion than HCO3- , most probably Cl- can be 
the driving force of fluid secretion. To study the source of basolateral Cl- uptake, we 
tested the role of NKCC1 by means of examination of the effect of cotransport 
inhibitor bumetanide. Bumetanide (100 µmol/l) completely blocked forskolin-evoked 
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fluid secretion in HEPES-buffered, and also in  HCO3--buffered solutions (Figure 4A 
and 4B). Bumetanide was applied after 10 minutes of forskolin stimulation. 
Pretreatment with bumetanide completely inhibited forskolin evoked fluid secretion in 
HCO3--buffered solution (Figure 4C) The complete inhibition of fluid secretion by 
bumetanide in HCO3--buffered solution suggests the central role of Cl- transport and 
only the marginal role of HCO3- transport in this process.  
 
Figure 4. Effect of different inhibitors on forskolin-evoked ductal fluid secretion 
in rabbit LG interlobular ducts. (A) Ducts were superfused with HEPES buffered 
solution throughout the experiments. From 10 minutes, ducts were exposed to 10 
µmol/l forskolin, from 20 minutes, ducts were exposed either to no blocker (only 
forskolin stimulation, filled square) or to 100 µmol/l bumetanide (empty triangle). (B) 
Ducts were superfused with HEPES buffered solution for 10 minutes (data not 
shown) and then the perfusate was switched to HCO3-/CO2 buffered solution. After 10 
minutes of superfusion with HCO3-/CO2 buffered solution, ducts were exposed to 
10 µmol/l forskolin. From 20 minutes, ducts were exposed either to no blocker (only 
forskolin stimulation, filled square) or to 100 µmol/l bumetanide (empty triangle). (C) 
Ducts were superfused with HEPES buffered solution for 10 minutes (data not 
shown) and then the perfusate was switched to HCO3-/CO2 buffered solution. From 10 
minutes, ducts were exposed either to 100 µmol/l bumetanide (empty triangle), or no 
blocker (filled square). From 20 minutes, all ducts were exposed to 10 µmol/l 
forskolin. (D) Ducts were superfused with HEPES buffered solution for 10 minutes 
(data not shown) and then the perfusate was switched to HCO3-/CO2 buffered solution. 
After 10 minutes of superfusion with HCO3-/CO2 buffered solution, ducts were 
exposed to 10 µmol/l forskolin. From 20 minutes ducts were exposed to 3 µmol/l 
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EIPA and 100 µmol/l DIDS (empty square). Administration of EIPA and DIDS 
without bumetanide did not cause statistically significant reduction in forskolin-
evoked fluid secretion. Changes in relative luminal volume (Vr) are shown. Data was 
obtained from five ducts isolated from at least three different animals in each series 
and is presented as the mean ± SEM. 
4.1.4. The role of basolateral HCO3- transporters in fluid secretion  
 To study the contribution of basolateral HCO3- and Cl- transporters, we tested 
the role of inhibition of basolateral transporters potentially contributing to the HCO3- 
transport. NHE was inhibited by 3 µmol/l EIPA, and Na+-HCO3- cotransporter was 
inhibited by 500 µmol/l DIDS. In HCO3- -buffered solution, administration of EIPA 
and DIDS had no effect on forskolin-evoked fluid secretion while simultaneous 
administration of 30 µmol/l bumetanide, 3 µmol/l EIPA and 500 µmol/l DIDS 
completely inhibited fluid secretion evoked by forskolin (Figure 4D). 
These results suggest the key role of Cl- transport in fluid secretion in rabbit lacrimal 
gland interlobular ducts.  
4.1.5. Carbachol-stimulated fluid secretion of lacrimal gland 
interlobular ducts in the presence and in the absence of HCO3- 
 Carbachol were used in 10 µmol/l, 100 µmol/l, and 1mmol/l doses to stimulate 
ductal fluid secretion. No secretory response was detected at 10 µmol/l concentration, 
while ductal swelling observed at the concentration of 1 mmol/l did not produce 
higher value compared to data obtained during 100 µmol/l dose stimulation (data are 
not shown). Carbachol in 100 µmol/l was used as the lowest concentration producing 
the maximal obtainable effect in the experiments described thereinafter. 
 Effect of carbachol treatment on secretion of lacrimal gland ducts was 
investigated both in HEPES-buffered and in HCO3-/CO2-buffered solutions. In the 
first series of experiments ducts were perfused with HEPES-buffered solutions for 10 
min, followed by administration of 100 µmol/l carbachol to the bath solution. No 
secretion was observed in HEPES-buffered solution, while carbachol initiated ductal 
swelling representing the cholinergic effect-evoked ductal fluid secretion. Fluid 
secretion proved to be biphasic consisting of a continuous swelling in the first 5 
minutes followed by a plateau phase (Figure 5A).  
 The role of HCO3- in carbachol evoked fluid secretion was investigated in the 
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second series of experiments. Ducts were perfused with standard HEPES-buffered 
solution for 5 min (not shown in the figure 5B) followed by 10 min perfusion with 
HCO3-/CO2-buffered solution. One hundred µmol/l carbachol was then administered 
to the bath and swelling response was detected. Figure 5B shows mean data for the 
change in relative volume. Ducts did not show spontaneous fluid secretion in HCO3-
/CO2-buffered solution. The kinetics of carbachol stimulated ductal fluid secretion 
was very similar to those that observed in HEPES-buffered solution. The stimulatory 
effect of carbachol could be detected in the first 5 minutes, followed by a plateau 
phase. Administration of parasympatholytic atropine resulted in a complete 
abolishment of carbachol-evoked fluid secretion both in HEPES-buffered and in 
HCO3-/CO2-bufered solutions (Figure 5A and 5B). 
 
Figure 5.  Effect of carbachol on ductal fluid secretion in LG gland interlobular 
ducts in the presence or in the absence of HCO3-. (A) Ducts were superfused with 
HEPES buffered solution throughout the experiments. From 5 minutes ducts were 
exposed either to 100 µmol/l atropine (empty triangle, arrow indicates the initiation of 
atropine treatment) or no blocker (filled square). From 10 minutes all ducts were 
exposed to 100 µmol/l carbachol. (B) Ducts were superfused with HEPES buffered 
solution for 10 minutes (data not shown) and then the perfusate was switched to 
HCO3-/CO2 buffered solution. From 5 minutes, ducts were exposed either to 
100 µmol/l atropine (empty triangle, arrow indicates the initiation of atropine 
treatment) or no blocker (filled square). From 10 minutes, all ducts were exposed to 
100 µmol/l carbachol. Changes in the relative luminal volume (Vr) are shown. Data 
was obtained from five ducts isolated from at least three different animals in each 
series and is presented as the mean ± SEM. 
Calculated secretory rates did not show a substantial difference measured in 
HEPES-buffered and HCO3-/CO2 -buffered solutions (Figure 6).  
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Figure 6. Calculated secretory rates of LG interlobular ducts evoked by 
forskolin and carbachol. Secretory rates (Jv) were calculated from data shown in 
Figures 4 and 5 and are expressed in picoliter (pl) secreted fluid per minute per 
millimeter squared luminal epithelial surface. Secretory rates were calculated from the 
change in relative luminal volume in the first 10 minutes of carbachol or forskolin 
stimulation. Secretory rates evoked by carbachol or by forskolin both in HEPES 
buffered and HCO3-/CO2 buffered solutions were significantly higher, compared with 
controls (i.e., fluid secretion in the corresponding buffer solutions without stimulatory 
agent). *P < 0.001. 
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4.2. Effect of bile acids on pancreatic ductal cells 
4.2.1. Effect of UDCA and CDCA on pHi 
 Several studies have shown that bile acids induce intracellular acidification in 
various cell types [68,95–97]. At first step, we have investigated the effect of CDCA 
and UDCA on basal pHi of pancreatic ducts. Administration of CDCA induced a 
dose-dependent intracellular acidification in Hepes-buffered solution (Figure 7A). 
The effect of CDCA on pHi was reversible, following the removal of bile acid from 
the external solution, the pHi completely returned to the basal level. UDCA also 
induced a dose-dependent decrease in pHi, however the effect of UDCA was much 
smaller compared to CDCA (Figure 7B). We repeated these experiments in HCO3-
/CO2-buffered solution, where the two bile acids induced similar degrees of pHi 
decrease (Figure 7C and D). Summary of the changes of pHi is shown in Figure 7E 
and F.  
 
Figure 7. Effect of bile acids on the intracellular pH (pHi) of pancreatic duct. 
Pancreatic duct epithelial cells (PDECs) were exposed to 0.1, 0.25, 0.5 and 1 mM 
CDCA (A and C) and UDCA (B and D) in Hepes (A and B) and in HCO3-/CO2-
buffered (C and D) solutions for 5 minutes. After the removal of bile acids the pHi 
spontaneously recovered. Summary data for the maximal pHi change (ΔpHmax) 
induced by bile acids in Hepes (E) and in HCO3-/CO2-buffered (F) solutions. The 
start point pHi for the measurment of ΔpH was the pHi immediately before exposure 
to bile acids. Data are presented as means ± SEM. n=32-34 regions of interest from 4-
5 ducts. N.D.: not detectable. 
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4.2.2. Effect of UDCA pretreatment on the inhibitory effect of CDCA on 
the acid/base transporters 
We used the ammonium pre-pulse technique to investigate the acid-base 
transporters of the pancreatic ducts. In HCO3--free solution the initial recovery from 
the acid phase is due to the activity NHE (Figure 8A). In the presence of HCO3- the 
recovery from alkalosis reflects the activity of the AEs, whereas the recovery from 
acidosis results from the activity of both NHE and NBC (Figure 8B). Two NH4Cl 
pulses were applied, the first was the control and the second was the test. To estimate 
the effect of bile acids on the activity of acid-base transporters CDCA (1 mM) and 
UDCA (0.1, 0.25, 0.5 and 1 mM) were administered 3 minutes before the pulse, 
during the pulse and 5 minutes after the pulse. Acute administration of UDCA did not 
affect the rate of recovery from the acid or alkali load neither in Hepes-buffered nor in 
HCO3-/CO2-buffered solutions (data not shown). In contrast, 1 mM CDCA strongly 
inhibited the activity of the acid/base transporters. (Figure 8A and B) Next we tested 
whether UDCA administration can influence the inhibitory effect of CDCA. When 
UDCA and CDCA were added simultaneously, UDCA was unable to prevent the 
inhibitory effect of CDCA on the ion transporters in all of the investigated 
concentration. (data not shown) Several studies have shown that prolonged incubation 
of the cells with UDCA is needed to exert its protective effect [85,98–100]. 
Therefore, in the next step, we pretreated the ducts with UDCA for various time 
periods (5h and 24 h) and the effect of CDCA on the ion transporters was examined. 
A 5 h preincubation of the ducts with UDCA (0.1, 0.25, 0.5 and 1 mM) did not affect 
the response to CDCA. However, 24 h pretreatment with UDCA significantly 
decreased the toxic effect of CDCA both in Hepes (Figure 8A) and in HCO3-/CO2-
buffered (Figure 8B) solutions. The lowest concentration of UDCA which had a 
protective effect was 0.5 mM (Figure 8A and B), whereas at higher concentrations (1 
mM) the protective effect of UDCA was significantly decreased. Therefore, we 
decided to use 0.5 mM UDCA in the subsequent experiments. Summary data of the 
base fluxes (±J(B-/min)) are shown on Figure 8C-E. As shown, pretreatment of the 
ducts with 0.5 mM UDCA prevented the inhibitory effect of CDCA on NHE (Figure 
8C), CBE (Figure 8D) and NBC (Figure 8E). 
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Figure 8. Effect of bile acids on the acid-base transporters of pancreatic duct. 
The activities of the ion transporters were investigated by the ammonium pre-pulse 
technique (see Materials and Methods). Administration of 1 mM CDCA was proved 
to be toxic on acid-base transporters both in standard HEPES (A) and HCO3-/CO2-
buffered (B) solutions. 0.5 and 1 mM UDCA pretreatment ameliorated the CDCA-
induced toxicity on the transporters both in HEPES (A) and HCO3-/CO2-buffered (B) 
solutions. Regeneration from acidosis in standard HEPES-buffered solution reflects 
the activity of NHE (C), whereas the recovery from acidosis (D) and alkalosis (E) in 
HCO3-/CO2containing solutions reflects the activities of Na+/HCO3- cotransporter and 
Cl-/ HCO3- exchanger, respectively. -J(B-) and J(B-) were calculated from the ∆pH/∆t 
obtained by linear regression analysis of pHi measurements made over the first 30 or 
60s, respectively. Data are presented as means ± SEM. *=p≤0.05 vs. control, n=36-41 
regions of interest from 6-7 ducts. N.D.: not detectable. 
4.2.3. Effect of UDCA pretreatment on the CDCA-induced calcium 
signaling 
 Numerous studies have indicated that bile-induced toxic calcium signalling is 
an initial step in the development of AP [101–104]. We have previously shown that 
high concentration of CDCA induces (Ca2+) elevation in ductal cells [68]. So in the 
next step we have examined whether UDCA pretreatment has any effect on the 
CDCA-induced Ca2+ signalling. Administration of 0.5 mM UDCA alone had no 
significant effect on [Ca2+]i (data not shown). In contrast, 1 mM CDCA induced high 
and partially reversible Ca2+ signalling in pancreatic ducts. (Figure 9A) Preincubation 
of the ducts with 0.5 mM UDCA for 24 h did not affect the CDCA-induced increase 
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in [Ca2+]i, (Figure 9A and B) indicating that the protective effect of UDCA is unlikely 
to be caused be the prevention of the elevated [Ca2+]i.  
4.2.4. Effect of UDCA pretreatment on the CDCA-induced 
mitochondrial injury  
 Injury of the mitochondra may lead to cell death [105,106]. Results from our 
laboratory shown that beside the elevated Ca2+ signalling, CDCA strongly damages 
mitochondria and causes ATPi depletion in pancreatic ducts which may contribute to 
the inhibitory effect of CDCA on ion transporters due to bioenergetic failure [74]. 
Therefore, in the next series of experiments we performed both functional and 
morphological studies to characterize the effect of UDCA pretreament on CDCA-
induced mitochondrial injury.  
 The ATPi  level is a good indicator of mitochondrial function; therefore in the 
first step we measured changes in ATPi in cells exposed to CDCA with or without 
UDCA pretreatment. As shown on Figure 9C, administration of 1 mM CDCA caused 
a huge and irreversible ATPi loss in PDECs. (Figure 9C) In contrast, 24 h 
preincubation of the cells with 0.5 mM UDCA reduced the rate of CDCA-induced 
ATPi decrease by 57.6±3.6 % (Figure 9C and D). UDCA administration alone did not 
effect ATPi. 
 To further analyse the protective effect of UDCA on ductal mitochondria, we 
also investigated ΔΨm and mPTP upon administration of bile acids. Ducts were 
incubated with 1 µM TMRM in order to investigate the changes in ΔΨm (see Material 
and Methods section). After the stabilisation of the mitochondrial fluorescence, 1 mM 
CDCA was applied and the fluorescence signal was monitored. As shown in Figure 
9E, the administration of CDCA resulted in a huge increase in TMRM fluorescence 
intensity, indicating that this bile acid induced marked mitochondrial depolarization. 
Preincubation of the ducts with 0.5 mM UDCA reduced the CDCA-induced 
depolarization by 69.4±4.6% (Figure 9E and F).  
 Since ATP depletion and mitochondrial depolarization are caused by mPTP 
induction, next we investigated the effect of CDCA on the opening of mPTP using the 
calcein-cobalt technique. Treatment of the calcein-loaded pancreatic ducts with 1 mM 
CDCA decreased the fluorescence excitation of calcein, approximately 1 min after the 
addition of the bile acid. (Figure 9G) Similarly to the ΔΨm experiments, 24 h 
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pretreatment of the ducts with 0.5 mM UDCA had a preventive role on mitochondria 
and decreased the CDCA-induced mPTP opening by 72.1±4%. (Figure 9G and H) 
Administration of UDCA alone did not affect mPTP. 
 
Figure 9. Effect of bile acids on intracellular Ca2+ concentration ([Ca2+]i), ATP 
level (ATPi), mitochondrial membrane potential (ΔΨm) and mitochondrial 
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permeability transition pore (mPTP) of pancreatic duct. Representative 
experimental traces showing the effect of 1 mM CDCA on [Ca2+]i (A),  ATPi (C), 
ΔΨm (E) and mPTP opening (G) in non pretreated and 24h UDCA pretreated 
pancreatic ducts. (A) Acute administration of CDCA caused Ca2+ signalization in 
pancreatic ductal cells which was not affected by UDCA pretreatment. (C) Decrease 
in ATPi is shown by an increase in fluorescence intensity. As shown 24 h UDCA 
pretreatment markedly decreased the CDCA-induced ATP depletion. (E) Decrease in 
ΔΨm is shown by an increase in TMRM fluorescence intensity. Administration of 1 
mM CDCA caused rapid depolarization of the mitochondrial membrane which was 
decreased by UDCA pretreatment.  (G) mPTP opening is shown by a decrease in 
fluorescence intensity. CDCA-induced a marked mPTP opening which resulted in 
significant influx of Co2+ into the mitochondria causing a decrease in calcein 
fluorescence. 24 h UDCA pretreatment reduced CDCA-induced mPTP opening 
resulting in a milder decrease in calcein fluorescence. Summary data for the 
maximal fluorescence intensity changes are shown on Figure B, D, F and H. Data are 
presented as means ± SEM. *=p≤0.05 vs. 1 mM CDCA. n=35-40 regions of interest 
from 6-7 ducts.  
Mitochondrial morphology of the ducts was also examined by electron 
microscopy (Figure 10A-D). The mean number of mitochondria in the section of the 
control, the CDCA, the UDCA and the CDCA+UDCA groups was nearly the same. 
No morphological alterations were observed in the control and UDCA-treated groups. 
(Figure 10A and B) In contrast, incubation of the ducts with 1 mM CDCA for 5 min 
resulted in mitochondrial swelling and the loss of the mitochondrial inner membrane 
(Figure 10C). This swelling could be prevented by UDCA pretreatment. Moreover, 
the integrity of the mitochondria was also maintained in the CDCA+UDCA-treated 
ducts compared to the ducts only treated with CDCA (Figure 10D). 
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Figure 10. Effect of bile acids on the morphology of mitochondria. Representative 
electron micrograph images of pancreatic ductal mitochondria show normal 
mitochondria with intact inner membranes in the control and UDCA pretreated ducts 
(A and B). Treatment with 1 mM CDCA caused mitochondrial swelling after 5 min 
(C) which was completely prevented by 24 h UDCA pretreatment (D). Arrows show 
mitochondria. 
4.2.5. Effect of UDCA pretreatment on the CDCA-induced cell death 
 In the next step, we tested whether the toxic effect of CDCA on the 
mitochondria is associated with cell death. Ducts were treated with 1 mM CDCA for 
5 min, then were incubated in culture media for further 3 h in order to leave time for 
development of cell death. Cell death was assessed by TUNEL staining (Figure 11A 
and B). This method is based on the labelling of the 3’-OH ends of the fragmented 
DNA which are generated during cell death. Incubation of the pancreatic ducts with 
CDCA resulted in a significant increase in cell death compared to control, non-treated 
ducts. (Figure 11A and B) Although, both apoptosis and necrosis can be characterised 
by DNA fragmentation, the presence of intact cell organelles, cellular shrinkage and 
the lack of cellular content release indicate that CDCA rather induces apoptotic cell 
death than necrosis [107]. 24 h preincubation with UDCA (0.5 mM) alone caused 
only a small degree of DNA fragmentation in the ductal cells, but significantly 
reduced the CDCA-induced apoptotic cell death by 63.3±5.7 %. (Figure 11A and B) 
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Figure 11. Effect of UDCA pretreatment on CDCA-induced cell death on 
pancreatic ductal epithelial cells (PDECs). (A) Representative pictures of TUNEL 
positive and hematoxylin-eosin stained pancreatic duct segments show that incubation 
of the pancreatic ducts with 1 mM CDCA (left bottom) increased the rate of dead 
cells compared to control (left top) non-treated ducts. 5 min administration of UDCA 
(0.5 mM) alone, had no significant effect on the cells (right top), whereas 24 h 
pretreatment of the ducts with 0.5 mM UDCA (right, bottom) decreased the rate of 
dead cells in the CDCA-treated group. (B) Percentage of total cell counts that are 
TUNEL positive. Data are presented as means ± SEM. *=p≤0.05 vs. Control, ⧣=p≤0.05 vs. 1 mM CDCA , n=3-4.  
4.2.6. In vivo investigation of the effect of UDCA pretreatment in CDC-
induced AP model 
In order to investigate the protective effect of UDCA under in vivo conditions, 
we utilized a CDCA-induced pancreatitis model [108,109]. We used rats as the model 
animals because we were unable to administer CDCA intraductally in guinea pigs due 
to the anatomical topography of the main duct. 
 Serum amylase activities were significantly elevated after retrograde infusion 
of CDCA (CDCA group, 983±100 U/l) compared to intraductally administered 
physiological saline (control group, 396±50 U/l). Pretreatment of UDCA for two 
weeks did not influence the serum amylase activities (UDCA group, 424.7 ± 20) in 
control animals; however, it was significantly decreased (582 ± 50 U/l) in the 
UDCA+CDCA group versus the CDCA group (Figure 12A).  
 Pancreatic water content was significantly elevated after retrograde infusion of 
CDCA (80±1%) compared to intraductally administered physiological saline 
(60±1%). A two-week pretreatment with UDCA showed no influence on the 
 39 
pancreatic water content (61±2%) in the UDCA group. However in the 
UDCA+CDCA group, it was significantly decreased (65±2%) versus to the CDCA 
group (Figure 12B). 
 
Figure 12. Effect of UDCA pretreatment on CDCA-induced pancreatitis model 
in rats. Serum amylase activity (U/l) (A) pancreatic oedema (B) and cell necrosis (%) 
(C) increased by intraductal administration of CDCA, however 2 weeks UDCA 
pretreatment ameliorated each of these severity parameters. (D) Representative 
histological images of control, UDCA pretreated, CDCA-induced acute pancreatitis 
and UDCA pretreated CDCA-induced acute pancreatitis animals. Control rats were 
given physiological saline instead of CDCA. Scale bar = 100 µm. P.O.: per os, I.D.: 
intraductal. Data are presented as means ± SEM. *=p≤0.05 vs. Control, ⧣=p≤0.05 vs. 
1 mM CDCA , n=6 animals in each groups. Scale bar 100 µm. 
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5. DISCUSSION 
5.1. Investigation of lacrimal gland ductal secretion 
 The first part of this study provided the first experimental evidence of water 
permeability of LG ducts and the calculated values of osmotic permeability; and the 
first direct evidence of LG duct fluid secretion deriving from functional experiments 
evoked by forskolin and carbachol.  
 In contrast to many secretory epithelia, we are lacking of published 
calculations of the water permeability of the ductal epithelium, even through this 
parameter is essential in determining the ability of the fluid transport. It has been 
estimated that ductal cells may produce as much as 30% of the total volume of the 
lacrimal gland fluid, thus the relative contribution of ductal epithelial cells to water 
secretion cannot be neglected [42]. The summarized actions of basolaterally and 
apically located ion transporters, co-transporters and exchangers can produce an 
osmotic gradient which may determine the direction of water flow. Water passively 
follows secreted ions depending on the osmotic gradient and on the permeability of 
the epithelial structure.  
Similarly to pancreatic ducts, the isolated lacrimal gland duct segments seal 
spontaneously during overnight culturing, forming closed sac-like structures. 
Secretory processes of ductal epithelium into the closed intraluminal space result in 
swelling of the ducts as the luminal space fills with the fluid secreted as seen in the 
case of isolated pancreatic ducts [14,87,88,110]. The ductal volume changes can be 
analyzed by videomicroscopy [87,88]. 
 We measured the initial rate of swelling of LG ducts after a sudden drop in 
bath osmolarity caused by a Na+-gradient in order to characterize the water 
permeability properties of the structure. There was only minimal connective tissue 
surrounding the basolateral surface of the epithelium thus the unstirred layer effect 
could be neglected [111]. According to our observations, the sealing of the ends of the 
ducts results in complete restoration of epithelial integrity and swelling of the ducts 
happens without leakage in the vast majority of cases. The value of Pf proved to be 
60,53 µm/s (± 19,76). This Pf value is lower, than the highly water permeable 
pancreatic ductal epithelium (160-170 µm/s, measured in rat pancreatic ducts) or the 
kidney proximal tubule (100-500 µm/s, different species) and very similar to the 
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distal airways of the guinea pig (60 µm/s), to the rat cholangiocytes (50 µm/s) or to 
the cultured corneal endothelium in mice (74 µm/s) [46,89,112–116]. The Pf value 
showed by our experiments is clearly sufficient to support fluid secretion, and proves 
that rabbit lacrimal gland ductal epithelium is be able to secrete fluid in response to 
secretagogues. 
 Until recently, limited number of studies has focused on lacrimal duct 
function [14,45,47,48,117–119]. All of these studies investigated the ion secretory 
profile of ductal cells, while fluid secretory properties of ductal system remained 
speculative. Dartt et al. published a landmark study in 1981 proposing that the 
electrolyte and water component of lacrimal gland fluid could be a mixture of plasma-
like primary fluid secreted by the acinar cells and a potassium ion-rich fluid produced 
by the ductal cells [42]. They concluded that ductal cells may secrete a significant 
portion of lacrimal gland fluid. Using laser capture microdissection, Ding et al. 
anayzed the gene expression profile of various duct segments and the acinar cells with 
real-time RT-PCR in rabbit lacrimal gland. Predominant expression of CFTR was 
found in the duct cells along with the demonstration of the presence of certain 
transporters and aquaporins along the acinus-duct axis [117]. Another recent study 
found significant variations in the expression of different chloride channels in a rabbit 
model of Sjögren syndrome and in healthy animals [47]. The reduced levels of Na+-
K+-2Cl- cotransporter and CFTR mRNA in ductal cells derived from diseased animals 
suggest the active contribution of these structures in altered lacrimal fluid secretion. 
In a recent paper Lu and Ding elegantly demonstrated that CFTR is functionally 
involved in Cl- transport in both acinar and duct cells in the rabbit LG and suggests 
that CFTR plays a significant role in LG function [119]. The presence of significant 
amounts of CFTR in the ducts along with the detection of other channels and 
transporters in the LG duct cells strongly suggests that LG ducts play a critical role in 
the maintenance of homeostasis of lacrimal fluid secretion. 
 Forskolin stimulation was initiated a brisk and continuous swelling response 
in rabbit lacrimal gland interlobular ducts. Forskolin is a potent direct activator CFTR 
through cAMP elevation. Fluid secretion was unaffected by inhibition of HCO3- 
transport mechanisms, but completely abolished when basolateral Cl- uptake was 
blocked by bumetanide suggesting the predominant role of Cl- transport mechanisms 
over HCO3- secreting processes in lacrimal duct fluid secretion in rabbit. As 
bumetanide is a well known inhibitor of the Na+-K+-2Cl- cotransporter located on the 
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basolateral membrane of the duct cells, this transport process can be the main  route 
of cellular cloride uptake. Further studies are needed to determine the functional 
activity of this transporter. 
LG secretion through M3 muscarinic receptors is well established [42,45,120–
125]. Cholinergic stimulation with carbachol resulted in a biphasic secretory response 
with a faster initial and a plateau second phase in our experiments. The kinetics of 
swelling response was in accordance with the carbachol-evoked changes of 
intracellular calcium levels of lacrimal ductal cells reported earlier by our laboratory 
[14]. Carbachol-evoked secretory pattern of lacrimal ducts was similar to those found 
in pancreatic ducts [87]. Parasympatholytic atropine abolished the stimulatory effect 
of carbachol, suggesting the involvement of muscarinic cholinoceptors. The secretory 
effects of forskolin were remarkably higher compared to the response to carbachol 
stimulation. We investigated the role of basolateral ion transport mechanisms only in 
case of forskolin stimulation. The relatively weak swelling response evoked by 
carbachol was a limitation to attempt to measure the effect of different transporters in 
case of carbachol stimulation.  
 In conclusion, besides water permeability, forskolin and carbachol induced 
fluid secretory capability of lacrimal gland ductal cells were demonstrated in the 
present work. Our results strongly support the hypothesis, that lacrimal gland ductal 
system is actively involved in lacrimal fluid secretion. Further studies are needed to 
clarify the effects of various stimulatory agents and the role of ion transport 
mechanisms in this process. Future results may contribute to the development of 
targeted pharmacological interventions in order to improve deteriorated lacrimal 
gland function in dry eye disease.  
5.2. Effect of bile acids on pancreatic ductal cells 
 In the second part of this study, we have shown that the hydrophilic bile acid, 
UDCA is able to attenuate the toxic effect of CDCA on pancreatic ducts by 
preventing CDCA-induced mitochondrial injury. 
The pathomechanism of biliary AP is not fully understood. Numerous studies 
indicated that bile reflux into the pancreas may lead to pancreatic injury and as a 
result can induce AP [63–65]. Therefore, a better understanding of the mechanisms 
underlying bile-induced pancreatic injury and its prevention may provide novel 
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therapeutic tools for the treatment of AP.  
 To study the effect of CDCA and UDCA we used isolated intra-interlobular 
pancreatic ducts, which is a reliable in vitro model for investigating pancreatic ductal 
damage. The CDCA concentration used in this study was previously shown to induce 
intracellular Ca2+ signalling, mitochondrial injury and inhibition of the acid-base 
transporters, whereas the concentrations of UDCA were chosen on the basis of the 
literature data [68,74,83,84]. Examinations were performed using 0.5 mM UDCA 
since the protective effect of UDCA was not increased by using higher concentrations 
(1 mM), whereas lower concentrations of this bile acid (0.1 and 0.25 mM) had no 
detectable protective effect. This concentration of UDCA is one magnitude higher 
than the physiological concentration of bile acid in the blood and several orders of 
magnitude lower than the concentration of bile acids in the gall bladder or duodenum 
(10-100 mM) [126]. The optimal preincubation time of pancreatic ducts with UDCA 
was found to be 24 h, indicating that the development of protective action is a 
complex mechanism which probably include changes at transcriptional level that 
modulate various signalling and apoptotic pathways [84,127,128]. 
 Our results indicaded that 24 h pretreatment of pancreatic ducts with 0.5 mM 
UDCA significantly reduced the inhibitory effect of CDCA on the acid/base 
transporters. Studies on pancreatic acinar cells have indicated that the toxic effect of 
hydrophobic bile acids is mediated by a sustained Ca2+ signalling [66,66]. We have 
previously shown that high concentration of CDCA induces a huge and long-lasting 
elevation of [Ca2+]i in pancreatic ducts [68]. Therefore, we tested whether the 
protective effect of UDCA on the acid/base transporters is due to the prevention of 
CDCA-induced calcium signalling. When pancreatic ducts were exposed to UDCA 
for 24 h and CDCA was then added, the extent of calcium elevation did not change, 
indicating that the protective effect of UDCA is unlikely to be caused by the reduction 
of Ca2+ signalling. This finding is in accordance with our previous observation on 
pancreatic ducts, where preincubation of the cells with a specific calcium chelator, 
BAPTA-AM was unable to prevent the inhibitory effect of CDCA on acid-base 
transporters [68].  
 Numerous studies support the concept that mitochondrial damage plays a 
central role in the bile acid-induced cellular injury and that UDCA pretreatment is 
able to attenuate the toxic effect of hydrophobic bile acids on mitochondria 
[81,83,84]. Therefore, in the next step we investigated the protective effect of UDCA 
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on the function and morphology of pancreatic ductal mitochondria. Administration of 
CDCA alone induced mPTP opening in the ductal cells. This is an early event in cell 
death which leads to mitochondrial swelling due to an increase in the mitochondrial 
inner membrane permeability. mPTP is also characterized by the loss of membrane 
potential which leads to mitochondrial dysfunction and consequently inhibition of 
ATP synthesis. Studies on rat hepatocytes demonstrated that in the presence of the 
specific mPTP inhibitor, cyclosporine A, the effect of CDCA was completely 
ameliorated indicating that CDCA selectively acts on mPTP [129]. It has been also 
demonstrated that CDCA induces mPTP due to increased membrane fluidity and 
cytochrome c release in calcium-loaded hepatic mitochondria [130]. In contrast to the 
effects of CDCA, UDCA alone caused no significant changes in mitochondrial 
function. However, UDCA pretreatment was able to prevent the CDCA-induced 
mPTP, mitochondrial membrane perturbation and the consequently formed decrease 
in membrane potential. Moreover, UDCA prevented the CDCA-induced ATPi loss, 
which provides further evidence that UDCA pretreatment is beneficial to avoid 
mitochondrial injury. This conclusion was confirmed by electron microscopic studies 
which showed normal appearance of mitochondria in the UDCA+CDCA group 
compared to the CDCA group, where mitochondrial swelling and disruption of the 
inner mitochondrial membrane were observed. The mechanism underlying the 
mitochondrial protective effect of UDCA is not clear. One of the main inducers of 
mPTP is Ca2+ overload and oxidative stress. Although, we have shown that UDCA 
pretreatment had no effect on the extent of CDCA-induced Ca2+ elevation, we did not 
investigate the effect of UDCA on the total Ca2+ load. It is possible that the protective 
effect of UDCA is due to the reduction of Ca2+ overload or by the inhibition of 
reactive oxygen species (ROS) production, however further studies are needed to 
confirm these hypotheses. 
 Mitochondrial dysfunction is often associated with cell death either by the 
reduction of ATPi levels or by irreversible alterations in the mitochondrial membrane 
permeability which induces the release of apoptotic signalling molecules from the 
mitochondria. Since mitochondria play a central role in cell survival, we wanted to 
determine if the CDCA-induced mitochondrial injury would result in cell death and to 
examine the possible protective role of UDCA in this process. Administration of 
CDCA induced marked DNA fragmentation in intact pancreatic ducts. We speculate 
that impairment of mitochondrial function plays a central role in this mechanism, but 
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other signalling pathways may be involved. The apoptotic effect of CDCA and other 
hydrophobic bile acids have been examined in more detail in hepatocytes. ROS 
generation, mPTP induction, cytochrom c release and activation of downstream 
caspases have been shown to be associated with apoptosis [131,132]. It has been also 
demonstrated that the glycin-conjugated form of CDCA, directly stimulate Fas-
dependent cell death due to the activation of the Fas receptor which is independent 
from the mitochondrial pathway [133]. 24 h pretreatment with UDCA effectively 
reduced the CDCA-induced apoptosis as indicated by significantly decreased DNA 
fragmentation which further confirms the cytoprotective effect of UDCA. The exact 
mechanism by which UDCA exerts its protective effect was not investigated by our 
group; however, our results and previous studies on hepatocytes strongly indicate that 
mPTP inhibition by UDCA is one of the key mechanisms in the reduction of CDCA-
induced cell death in PDECs. 
 In vivo experimental models are essential to confirm in vitro results. In order 
to extend our study, we also tested the protective effect of UDCA in animal models. 
There is no accepted bile acid-induced pancreatitis model in guinea pigs; therefore we 
induced AP in rats by intraductal injection of low concentration of CDCA [108,109]. 
Under these experimental conditions, CDCA induced acinar cell damage and also 
increased serum amylase activity. Previous studies on isolated rat and mouse acini 
demonstrated that the hydrophobic bile acid, TLC-S induces mitochondrial injury, 
pathological Ca2+ signalling and the generation of ROS [69,72,73,134]. We speculate 
that similar intracellular mechanisms may also have arisen in response to CDCA. The 
CDCA-induced acinar cell injury, hyperamylasemia and pancreatic edema was 
markedly reduced in the UDCA-treated group. The protective effect of UDCA can be 
attributed to its ability to reduce mitochondrial injury both in acinar and ductal cells. 
However, further in vitro experiments are needed to prove that UDCA pretreatment 
may exert a protective effect against the CDCA-induced acinar cell damage. Lastly, 
our results may have important clinical implication in patients with gallstone 
obstruction, where oral administration of UDCA or its metabolically stable form may 
reduce the risk of pancreatitis development. The beneficial effect of UDCA treatment 
has been demonstrated in idiopathic recurrent pancreatitis where long-term UDCA 
treatment reduced the rate of recurrence by prevention of the formation of gallstones 
[135–137]. The effect of orally administered UDCA is highly dependent on its 
metabolism. In rats, most of the UDCA is metabolized to TUDCA  which also has 
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cytoprotective effect as demonstrated in the liver [82,85,138,139]. In humans, one of 
the major metabolites of UDCA is isoursodeoxycholic acid (isoUDCA) which is the 
3β-hydroxy epimer of UDCA and has been shown to be more effective than UDCA 
[140,141]. In the current study, we have not investigated the serum concentration of 
UDCA after oral administration. Notably, since UDCA was administered in an excess 
dose, we believe that sufficiently high concentration of UDCA (or TUDCA) was 
present in the serum to exert its protective effect.  
 Understanding the early injury mechanisms induced by hydrophobic bile acids 
is extremely important to find a therapeutic target to reduce pancreatic injury. In this 
study, we confirm and extend our previous observations that mitochondria is a key 
target in the CDCA-induced cellular injury in PDECs. The hydrophilic bile acid, 
UDCA inhibits CDCA-induced apoptosis probably by the stabilization of 
mitochondrial membrane via the block of membrane depolarization and mPTP and 
also by prevention of mitochondrial swelling (Figure 10). Several studies have 
focused on the inhibition of cellular injury during AP in order to stop or delay the 
progression of the disease. UDCA may represent a novel option against the bile-
induced ductal injury, however issues for the therapeutic application of this bile acid 
in AP need further investigation. 
6. SUMMARY 
The investigation of epithelial functions under physiological and 
pathophysiologycal conditions is essential for the better understanding of their role in 
the body and their related diseases.  
We have very limited information about the role of LG ducts in tear secretion. 
Pancreatic research provided useful tools to study the LG ductal functions and opened 
new potentials in LG research .  
Thanks to these tools, in the past decades our knowledge were increasing from the 
physiology and patophysiology of the exocrine pancreas, although there are still many 
open questions. One of this questions is the pathomechanism of the biliary AP. Better 
understanding of the disease may lead to the development of new therapeutical 
approaches.  
Therefore this work was aimed to demonstrate the importance of physiological 
characterisation of epithelial cells and to study their function under 
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pathophysiological conditions. 
6.1. Investigation of lacrimal gland ductal secretion 
In the first part of this study our AIM was to investigate the osmotic water 
permeability of LG duct epithelium by means of calculation of filtration permeability 
and to investigate LG ductal fluid secretion with the following METHODS: 
Experiments were performed on isolated rabbit LG duct segments maintained in 
short-term culture. Osmotically determined fluid movement or fluid secretion into the 
closed intraluminal space of cultured LG interlobular ducts was analyzed using video 
microscopic technique. 
Therefore our RESULTS were:  
• The end of the LG ducts sealed after overnight incubation forming a closed 
luminal space.  
• For the calculation of osmotic water permeability, ducts were initially 
perfused with isotonic HEPES buffered solution, and then with hypotonic HEPES 
buffered solution. Filtration permeability was calculated from the initial slope of the 
relative volume increase. 
•  Secretory responses to carbachol or to forskolin stimulation were also 
investigated. Forskolin stimulation resulted in a rapid and sustained secretory 
response in both solutions. Forskolin- stimulated fluid secretion was completely 
inhibited by bumetanide both in HEPES buffered and in HCO3-/CO2 buffered 
solutions, suggesting the central role NKCC1.  
• Administration of carbachol initiated a rapid but short secretory response in 
both HEPES buffered and in HCO3-/CO2 buffered solutions. Atropine completely 
abolished the carbachol-evoked fluid secretion. 
CONCLUSIONS from the results:  
(i) A new method was introduced to investigate LG duct function.  
(ii) Water permeability of rabbit LG duct epithelium was measured by calculating 
filtration permeability.  
(iii) Fluid secretion of LG duct cells induced by carbachol or forskolin was also 
demonstrated. These results provide calculated values of lacrimal duct osmotic 
permeability and direct experimental evidence of LG duct fluid secretion. 
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6.2. Effect of acids on pancreatic ductal cells  
Earlier studies showed that CDCA strongly inhibits pancreatic ductal HCO3- 
secretion through the destruction of mitochondrial function, which may have 
significance in the pathomechanism of AP. UDCA is known to protect the 
mitochondria against hydrophobic bile acids and has ameliorating effect on cell death 
in heptocytes. Therefore, our AIM was to investigate whether UDCA pretreatment 
has any effect on CDCA-induced pancreatic ductal injury.  
To study ductal functions under phatophysiological conditions we used the 
following METHODS:   
• Guinea pig intra-interlobular pancreatic ducts were isolated by collagenase 
digestion. Ducts were treated with UDCA for 5 and 24 h and the effect of CDCA on 
intracellular Ca2+ concentration ([Ca2+]i), pH (pHi), morphological and functional 
changes of mitochondria, and the rate of apoptosis were investigated.  
• AP was induced in rat by retrograde intraductal injection of CDCA (0.5%) and 
the disease severity of pancreatitis was assessed by measuring standard laboratory and 
histological parameters. 
Using in vitro and in vivo approaches our RESULST showed that UDCA 
pretreatment:  
• completely prevented the inhibitory effect of CDCA on ductal acid-base 
transporters, 
• decreased the rate of CDCA-induced mitochondrial injury and cell death  
• reduced the severity of experimental AP induced by CDCA. 
Therefore our CONCLUSION is that these results clearly demonstrate that 
UDCA: 
(i) suppresses the CDCA-induced pancreatic ductal injury by reducing apoptosis 
and mitochondrial damage 
(ii) reduces the severity of CDCA-induced AP.  
 The protective effect of UDCA against hydrophobic bile acids may represent a 
novel therapeutical target in the treatment of biliary AP. 
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